<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Tsoumakidou Lab]]></title><description><![CDATA[Innovating Immunotherapy for Cancer Solutions]]></description><link>https://www.tsoumakidoulab.com/news</link><generator>RSS for Node</generator><lastBuildDate>Tue, 23 Jun 2026 10:42:39 GMT</lastBuildDate><atom:link href="https://www.tsoumakidoulab.com/blog-feed.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Exploring Antigen-Presenting Cells in Tumor Microenvironments]]></title><description><![CDATA[The tumor microenvironment (TME) is a complex and dynamic ecosystem that plays a crucial role in cancer progression and treatment response. Among the various cellular components of the TME, antigen-presenting cells (APCs) are pivotal in orchestrating immune responses against tumors. Understanding the function and behavior of APCs within the TME can provide insights into developing more effective cancer therapies. This blog post delves into the role of APCs in tumor microenvironments,...]]></description><link>https://www.tsoumakidoulab.com/post/exploring-antigen-presenting-cells-in-tumor-microenvironments</link><guid isPermaLink="false">698cf3d9636516a3166e44ee</guid><pubDate>Wed, 11 Feb 2026 21:25:45 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/844a98_c15b9b6f96914a25af5638168cdda4b4~mv2.png/v1/fit/w_1000,h_576,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Panagiotis Ieromnimon</dc:creator></item><item><title><![CDATA[Innovative Approaches in Cancer Immunotherapy Research]]></title><description><![CDATA[Cancer remains one of the leading causes of death worldwide, with millions of new cases diagnosed each year. Traditional treatments like chemotherapy and radiation have been the mainstay for decades, but they often come with severe side effects and limited effectiveness. In recent years, cancer immunotherapy  has emerged as a promising alternative, harnessing the body’s immune system to fight cancer more effectively. This blog post explores innovative approaches in cancer immunotherapy...]]></description><link>https://www.tsoumakidoulab.com/post/innovative-approaches-in-cancer-immunotherapy-research</link><guid isPermaLink="false">698cf3d20e15f11823ce6ff2</guid><pubDate>Wed, 11 Feb 2026 21:25:38 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/844a98_2a3d9e18a5b84282a5c7911270d29fee~mv2.png/v1/fit/w_1000,h_576,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Panagiotis Ieromnimon</dc:creator></item><item><title><![CDATA[The Future of Lung-On-Chip Technologies in Oncology]]></title><description><![CDATA[The fight against cancer has always been a complex and challenging endeavor. Traditional methods of studying cancer often rely on animal models or two-dimensional cell cultures, which can fail to accurately replicate human physiology. Enter lung-on-chip technologies, a groundbreaking innovation that promises to revolutionize oncology research and treatment. This blog post explores the future of lung-on-chip technologies in oncology, their potential applications, and the challenges that lie...]]></description><link>https://www.tsoumakidoulab.com/post/the-future-of-lung-on-chip-technologies-in-oncology</link><guid isPermaLink="false">698cf3cdd9c323c10df69b6f</guid><pubDate>Wed, 11 Feb 2026 21:25:33 GMT</pubDate><enclosure url="https://static.wixstatic.com/media/844a98_4c9e172fa76a42b0b4b259ff51ed6a00~mv2.png/v1/fit/w_1000,h_576,al_c,q_80/file.png" length="0" type="image/png"/><dc:creator>Panagiotis Ieromnimon</dc:creator></item></channel></rss>